Refacto | Tomguy

Refacto AF / Pfizer

Deliverables: Present Refacto's competitive claims in three compelling options for client review

ReFacto AF treats and prevents patients with Haemophilia A—a rare, inherited bleeding disorder in adolescents. Refacto's competitive claim is its purification process which minimizes the rate of therapy rejection. Preferred Option: “Stepping Up” plays on Refacto's technical feats and what that means for the patient.